Search This Blog

Sunday, September 6, 2026

Vaxcyte narrows VAX-31 OPUS-1 Phase 3 topline data guidance to the end of October

 

Vaxcyte narrows VAX-31 OPUS-1 Phase 3 topline data guidance to the end of October 2026, names Luis Jodar CMO and David McAvoy CLO

  • Luis Jodar, a former Pfizer vaccines executive, is appointed Vaxcyte's Chief Medical Officer.
  • David McAvoy, previously Teva's legal chief, joins Vaxcyte as Chief Legal Officer.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)